Significance of immunologic tolerance in dermatology;Bedeutung der immunologischen toleranz in der dermatologie

Hautarzt

Volumn 54, Issue 1, 2003, Pages 45-52

  Steinbrink, K ^a   Knop, J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Dendritic cell; Dermatology; Immunology; Tolerance

Indexed keywords

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; DENDRITIC CELL; DERMATOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; REVIEW; T LYMPHOCYTE ACTIVATION; ANIMAL; ARTICLE; B LYMPHOCYTE; CHILD; INFANT; NEWBORN; PRESCHOOL CHILD; SKIN DISEASE; T LYMPHOCYTE;

AUTOANTIGEN;

ANIMALS; AUTOANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; INFANT; INFANT, NEWBORN; SELF TOLERANCE; SKIN DISEASES; T-LYMPHOCYTES;

EID: 0038266800     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Kamradt T, Mitchison NA (2001) Tolerance and autoimmunity. N Engl J Med 344:655-664
2. Doniach D, Roitt IM (1976) Autoimmune thyroid disease. In: Doniach D, Roitt IM (eds) Texbook of immunopathology. Grune and Stratton, New York, pp 715-735
3. Schwartz RH (1996). Models of T cell anergy: is there a common molecular mechanism? J Exp Med 184:1-8
4. Steinbrink K, Wolfi M, Jonuleit H, Knop J, Enk AH (1997) Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772-4780
5. +-T cells resulting in a failure to lyse tumor cells. Blood 93:1634-1642
6. Sakaguchi S (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455-458
7. Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2:816-820
8. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1227-1238
9. Goodnow CC, Crosbie J, Adelstein S et al. (1998) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676-682
10. Klinman NR (1996) The clonal selection hypothesis' and current concepts of B cell tolerance. Immunity 5:189-195
11. Porakishvili N, Mageed R, Jamin C et al. (2001) Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol 54:30-38
12. Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340-350
13. Theofilopoulos AN, Kono DH (1999) The genes of systemic autoimmunity. Proc Assoc Am Physicians 111:228-240
14. Albert U, Inman RD (1999) Molecular mimicry and autoimmunity. N Engl J Med 341:2068-2074
15. Anderson CC, Matzinger P (2000) Danger: the view from the bottom of the diff. Semin Immunol 12:231-238
16. Nousari HC, Anhalt GJ (1999) Pemphigus and bullous pemphigoid. Lancet 354:667-672
17. Hertl M (2000) Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol 122:91-100
18. Schmidt E, Bröcker EB, Zillikens D (2000) New aspects on the pathogenesis of bullous pemphigoid. Hautarzt 51:637-645
19. Stanley JR, Nishikawa T, Diaz LA, Amagai M (2001) Pemphigus: is there another half of the story? J Invest Dermatol 116:489-490
20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
21. Wakeland EK, Liu K, Graham RR, Behrens TW (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity 15:397-408
22. Arnett FC (2000) Genetic studies of human lupus in families. Int Rev Immunol 19:297-317
23. Bröcker EB, Becker JC (1995) Die Immunologie des Melanoms. Hautarzt 46:818-828
24. Houghton AN, Gold JS, Blachere NE (2001) Immunity against cancer: lessons learned from melanoma. Curr Opin Immunol 13:134-140
25. Jäger D, Jäger E, Knuth A (2001) Vaccination for malignant melanoma: recent developments. Oncology 60:1-7
26. Smyth MJ, Godfrey DI, Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2:293-299
27. Nestle FO (2000) Dendritic cell vaccination for cancer therapy. Oncogene 19:6673-6679
28. Beissert S, Schwarz T (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig Dermatol Symp Proc 4:61-64
29. Ullrich SE, Schmitt DA (2000) The role of cytokines in UV induced systemic immune suppression. J Dermatol Sci 23 [Suppl 1]:S10-12
30. Norval M, Garssen J, Van Loveren H, el-Ghorr AA (1999) UV-induced changes in the immune response to microbial infections in human subjects and animal models. J Epidemiol 9:S84-89
31. Streilein JW, Taylor JR, Vincek V, Kurimoto I, Richardson J, Tie C, Medema JP, Golomb C (1994) Relationship between ultraviolet radiation-induced immunosuppression and carcinogenesis. J Invest Dermatol 103:107S-111S
32. Lindelof B, Sigurgelrsson B, Gabel H, Stern RS (2000) Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 143:513-519
33. Lushniak BD (2000) Occupational skin diseases. Prim Care 27:895-916
34. Enk AH, Katz (1995) Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105:80S-83S
35. Steinbrink K, Sorg C, Macher E (1996) Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J Exp Med 183:759-768
36. Steinbrink K, Kolde G, Sorg C, Macher E (1996) Induction of low zone tolerance to contact allergens in mice does not require functional Langerhans cells. J Invest Dermatol 107:243-247
37. Xu H, Dilulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+T cells and interleukin (IL) 4/IL-10-pruducing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001-1011
38. Battisto JR, Miller J (1962) Immunological unresponsivness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen. Proc Soc Biol Med 11:111-115
39. Komagata Y, Weiner HL (2000) Oral tolerance. Rev Immunogenet 2:61-73
40. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 146:485-491
41. Enk AH, Saloga J, Becker D, B1P6madzadeh M, Knop J (1994) Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 179:1397-1402
42. Luger TA, Brzoska T, Scholzen TE, Kalden DH, Sunderkotter C, Armstrong C, Ansel J (2000) The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci 917:232-238
43. Sy MS, Miller SD, Claman HN (1977) Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. J Immunol 119:240-244